RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com
  

Quark Pharmaceuticals Inc patents

Recent patent applications related to Quark Pharmaceuticals Inc. Quark Pharmaceuticals Inc is listed as an Agent/Assignee. Note: Quark Pharmaceuticals Inc may have other listings under different names/spellings. We're not affiliated with Quark Pharmaceuticals Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "Q" | Quark Pharmaceuticals Inc-related inventors




Date Quark Pharmaceuticals Inc patents (updated weekly) - BOOKMARK this page
03/23/17Methods and compositions for preventing ischemia reperfusion injury in organs
12/15/16Methods and compositions for neuroprotection
12/08/16Double stranded oligonucleotide compounds comprising positional modifications
11/17/16Double stranded rna compounds to rhoa and use thereof
11/17/16Oligonucleotide modulators of the toll-like receptor pathway
11/17/16Methods for delivery of sirna to the spinal cord and therapies arising therefrom
10/20/16Double-stranded rna compounds to casp2 and uses thereof
07/28/16Compositions and methods for treating lung disease and injury
04/14/16Double stranded rna compounds to rhoa and use thereof
12/17/15Composition of anti-endo180 antibodies and methods of use for the treatment of cancer and fibrotic diseases
12/17/15Methods for treating eye disorders
11/19/15Novel sirnas and methods of use thereof
09/24/15Double-stranded oligonucleotide molecules to ddit4 and methods of use thereof
09/17/15Double-stranded nucleic acid compounds
09/17/15Double-stranded nucleic acid compounds
07/23/15Double-stranded oligonucleotide molecules to p53 and methods of use thereof
06/11/15Oligonucleotide compounds comprising non-nucleotide overhangs
06/04/15Sirna compounds comprising terminal substitutions
05/21/15Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases
05/07/15Combination therapy for treating hearing and balance disorders
03/05/15Methods for delivery of sirna to the spinal cord and therapies arising therefrom
02/19/15Methods for treating eye disorders
01/29/15Methods and compositions for neuroprotection
01/15/15Double-stranded oligonucleotide compounds for treating hearing and balance disorders
12/18/14Double-stranded rna compounds to casp2 and uses thereof
12/11/14Combination therapy for treating hearing and balance disorders
11/27/14Rtp801l sirna compounds and methods of use thereof
10/30/14Methods and compositions for treating diseases, disorders or injury of the nervous system
05/22/14Methods for treating chronic kidney disease
03/13/14Composition of anti-endo180 antibodies and methods of use for the treatment of cancer and fibrotic diseases
03/06/14Compositions and methods for treatment of ear disorders
01/02/14Compositions and methods for treating lung disease and injury
12/05/13Double stranded oligonucleotide compounds comprising positional modifications
11/14/13Therapeutic uses of inhibitors of rtp801l
10/10/13Compositions and methods for inhibiting nadph oxidase expression
07/25/13Treatment or prevention of oto-pathologies by inhibition of pro-apoptotic genes
05/30/13Double stranded rna compounds to rhoa and use thereof
05/23/13Rtp801l sirna compounds and methods of use thereof
05/16/13Novel sirna structures
04/18/13Therapeutic uses of inhibitors of rtp801
07/19/12Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases
06/21/12Therapeutic uses of inhibitors of rtp801
05/31/12Compositions and methods of inhibiting nadph oxidase expression
05/03/12Therapeutic uses of inhibitors of rtp801l
02/09/12Screening systems utilizing rtp801
10/13/11Novel sirnas and methods of use thereof
09/22/11Oligoribonucleotide inhibitors of nrf2 and methods of use thereof for treatment of cancer
08/18/11Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases
07/21/11Modulation of hsp47 expression
04/28/11Inhibitors of rtp801 and their use in disease treatment
02/24/11Screening systems utilizing rtp801
07/01/10Therapeutic uses of inhibitors of rtp801l
02/04/10Treatment or prevention of oto-pathologies by inhibition of pro-apoptotic genes
10/22/09Sequences characteristic of hypoxia-regulated gene transcription
08/13/09Use of the endo-180 gene and polypeptide for diagnosis and treatment







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Quark Pharmaceuticals Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Quark Pharmaceuticals Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';